PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 4 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Acetone and water extracts of Cryptocarya latifolia inhibited the growth of both drug-sensitive and drug-resistant strains of M. tuberculosis in vitro [PMID:10473184].
Evidence summary
PubMed sources
- 1.PMID: 28852722 (2016) — PHYTOCHEMICAL, ELEMENTAL AND BIOTECHNOLOGICAL STUDY OF CRYPTOCARYA LATIFOLIA. · African journal of traditional, complementary, and alternative medicines : AJTCAM
- 2.PMID: 12762696 (2003) — Enantioselective syntheses of cryptocarya triacetate, cryptocaryolone, and cryptocaryolone diacetate. · Organic letters
- 3.PMID: 10473184 (1999) — In vitro inhibition of drug-resistant and drug-sensitive strains of Mycobacterium tuberculosis by ethnobotanically selected South African plants. · Journal of ethnopharmacology
- 4.PMID: 34810762 (2021) — Contribution to morphology, biology and distribution of Mecolenus wahlbergi Schoenherr, 1847, a relict African apionine weevil (Coleoptera: Brentidae: Apioninae). · Zootaxa